Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reaffirmed at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report released on Monday,Benzinga reports. They presently have a $69.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 22.95% from the stock’s previous close. Several other research analysts […]
More Stories
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (NASDAQ:GRID) Sees Strong Trading Volume – Should You Buy?
Shares of First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (NASDAQ:GRID – Get Free Report) saw unusually-high trading...
QUALCOMM (NASDAQ:QCOM) Shares Up 1.3% – What’s Next?
QUALCOMM Incorporated (NASDAQ:QCOM – Get Free Report) shares were up 1.3% during trading on Monday . The company traded as...
Teck Resources Target of Unusually High Options Trading (NYSE:TECK)
Teck Resources Limited (NYSE:TECK – Get Free Report) (TSE:TECK) was the target of some unusual options trading on Monday. Traders...
Cracker Barrel Old Country Store (NASDAQ:CBRL) Shares Down 4.8% – What’s Next?
Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL – Get Free Report) fell 4.8% on Monday . The stock traded as...
Botswana Diamonds (LON:BOD) Shares Up 37.5% – Here’s Why
Botswana Diamonds plc (LON:BOD – Get Free Report) shares rose 37.5% during mid-day trading on Monday . The company traded...
Altimmune (NASDAQ:ALT) Stock Price Down 4.6% – Here’s Why
Altimmune, Inc. (NASDAQ:ALT – Get Free Report)’s stock price traded down 4.6% during trading on Monday . The stock traded...